Treatments
Long COVID patients push to see federal research refocused on treatments
The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs.
Alzheimer’s timeline shows changes start as trickle, become torrent
A study of cells from 84 brains finds that Alzheimer’s has two distinct phases, and that one type of neuron is especially vulnerable.
